Lifeng Fu

2.0k total citations · 1 hit paper
38 papers, 1.1k citations indexed

About

Lifeng Fu is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Lifeng Fu has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in Lifeng Fu's work include Influenza Virus Research Studies (7 papers), Computational Drug Discovery Methods (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Lifeng Fu is often cited by papers focused on Influenza Virus Research Studies (7 papers), Computational Drug Discovery Methods (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Lifeng Fu collaborates with scholars based in China, United States and Czechia. Lifeng Fu's co-authors include Jianxun Qi, George F. Gao, Yi Shi, Xuebing Li, Yan Wu, Gary Wong, Hao Song, Weili Kong, Zhenjun Li and Ri‐He Peng and has published in prestigious journals such as Nucleic Acids Research, Advanced Materials and Nature Communications.

In The Last Decade

Lifeng Fu

36 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease

2020 392 citations Lifeng Fu, Fei Ye et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lifeng Fu China	15	447	437	283	175	173	38	1.1k
Saeed Banawas Saudi Arabia	21	318 0.7×	307 0.7×	97 0.3×	118 0.7×	171 1.0×	70	1.2k
Jian Lei China	16	442 1.0×	762 1.7×	143 0.5×	62 0.4×	178 1.0×	42	1.5k
Pedro Henrique Monteiro Torres Brazil	17	450 1.0×	310 0.7×	239 0.8×	45 0.3×	250 1.4×	44	1.2k
Lake N. Paul United States	19	618 1.4×	179 0.4×	65 0.2×	70 0.4×	147 0.8×	35	1.1k
Wenzhang Chen China	10	238 0.5×	322 0.7×	67 0.2×	76 0.4×	52 0.3×	20	943
Desh Deepak Singh India	23	480 1.1×	254 0.6×	49 0.2×	130 0.7×	94 0.5×	86	1.2k
Prakash Saudagar India	19	337 0.8×	128 0.3×	84 0.3×	77 0.4×	296 1.7×	57	975
Syed Aun Muhammad Pakistan	17	547 1.2×	119 0.3×	47 0.2×	106 0.6×	150 0.9×	98	1.2k
Íñigo Angulo‐Barturen Spain	22	471 1.1×	475 1.1×	237 0.8×	29 0.2×	258 1.5×	36	1.4k
Subhomoi Borkotoky India	15	381 0.9×	139 0.3×	102 0.4×	73 0.4×	31 0.2×	28	681

Countries citing papers authored by Lifeng Fu

Since Specialization

Citations

This map shows the geographic impact of Lifeng Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifeng Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifeng Fu more than expected).

Fields of papers citing papers by Lifeng Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifeng Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifeng Fu. The network helps show where Lifeng Fu may publish in the future.

Co-authorship network of co-authors of Lifeng Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Lifeng Fu. A scholar is included among the top collaborators of Lifeng Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifeng Fu. Lifeng Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Shuchi, Muhammad Usman, Qingyu Wu, et al.. (2025). The impact of post-translational modifications and subcellular localization on NLRP3 inflammasome activation: A systematic review. Cell Communication and Signaling. 23(1). 426–426.

Zhang, Yu, et al.. (2025). GTOC12: Methods and results from the National University of Defense Technology. Astrodynamics. 9(1). 129–141. 2 indexed citations

Wang, Juan, Jasper Fuk‐Woo Chan, Jiao Zhou, et al.. (2025). Discovery of a potent covalent inhibitor that unusually distorts the catalytic dyad of SARS-CoV-2 main protease. Journal of Virology. 99(10). e0065825–e0065825.

Fu, Lifeng, Yan Li, Elisabeth Zeuko’o Menkem, et al.. (2024). Insights into the inhibition mechanisms of MERS-CoV and SARS-CoV2 papain-like proteases by inhibitors from Crinum distichum: In vitro and in silico analysis. South African Journal of Botany. 165. 290–306. 3 indexed citations

Liu, Ruili, Junqing Sun, Lian‐Feng Li, et al.. (2024). Structural basis for difunctional mechanism of m-AMSA against African swine fever virus pP1192R. Nucleic Acids Research. 52(18). 11301–11316. 3 indexed citations

Liang, Wenqing, Chao Zhou, Hongwei Zhang, et al.. (2024). Current advancements in therapeutic approaches in orthopedic surgery: a review of recent trends. Frontiers in Bioengineering and Biotechnology. 12. 1328997–1328997. 23 indexed citations

Yang, Jinyue, Min Wang, Yongqi Li, et al.. (2024). De Novo Discovery of a Noncovalent Cell-Penetrating Bicyclic Peptide Inhibitor Targeting SARS-CoV-2 Main Protease. Journal of Medicinal Chemistry. 67(22). 20258–20274. 4 indexed citations

Deng, Yongjun, Chao Zhou, Lifeng Fu, et al.. (2023). A mini-review on the emerging role of nanotechnology in revolutionizing orthopedic surgery: challenges and the road ahead. Frontiers in Bioengineering and Biotechnology. 11. 1191509–1191509. 9 indexed citations

Chen, Jie, Xiang Zhou, Lifeng Fu, & Haiyu Xu. (2023). Natural Product-Based Screening for Lead Compounds Targeting SARS CoV-2 Mpro. Pharmaceuticals. 16(5). 767–767. 8 indexed citations

10.

Lu, Hailin, et al.. (2022). Organic solvents enhance polyvinyl alcohol/polyethylene glycol self‐healing hydrogels for artificial cartilage. Polymers for Advanced Technologies. 33(10). 3455–3469. 13 indexed citations

11.

Yang, Jing, Cheng Zhang, Chenguang Shen, et al.. (2022). Genetic, biological and epidemiological study on a cluster of H9N2 avian influenza virus infections among chickens, a pet cat, and humans at a backyard farm in Guangxi, China. Emerging Microbes & Infections. 12(1). 2143282–2143282. 15 indexed citations

12.

Hou, Bo, Yumin Zhang, Lifeng Fu, et al.. (2022). Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2. Journal of Natural Products. 85(2). 327–336. 15 indexed citations

13.

Jiang, Hong, Jie Chen, Liping Kang, et al.. (2022). Systematic identification of chemical components in Fufang Shuanghua oral liquid and screening of potential active components against SARS-CoV-2 protease. Journal of Pharmaceutical and Biomedical Analysis. 223. 115118–115118. 11 indexed citations

14.

Fu, Lifeng, Shuai Shao, Yong Feng, et al.. (2021). Mechanism of Microbial Metabolite Leupeptin in the Treatment of COVID-19 by Traditional Chinese Medicine Herbs. mBio. 12(5). e0222021–e0222021. 25 indexed citations

15.

Peng, Qi, Ruchao Peng, Bin Yuan, et al.. (2021). Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir. The Innovation. 2(1). 100080–100080. 73 indexed citations

16.

Fu, Lifeng, Huiming Zhong, Zhihui Kuang, et al.. (2021). Low-dose IL-34 has no effect on osteoclastogenesis but promotes osteogenesis of hBMSCs partly via activation of the PI3K/AKT and ERK signaling pathways. Stem Cell Research & Therapy. 12(1). 268–268. 18 indexed citations

17.

Wang, Pengfei, Babayemi Olawale Oladejo, Lifeng Fu, et al.. (2021). Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors. RSC Advances. 11(16). 9528–9541. 12 indexed citations

18.

Fu, Lifeng, Fei Ye, Yong Feng, et al.. (2020). Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nature Communications. 11(1). 4417–4417. 392 indexed citations breakdown →

19.

Wang, Feibing, Weili Kong, Gary Wong, et al.. (2016). AtMYB12 regulates flavonoids accumulation and abiotic stress tolerance in transgenic Arabidopsis thaliana. Molecular Genetics and Genomics. 291(4). 1545–1559. 187 indexed citations

20.

Zhang, Yanquan, Lifeng Fu, Changming Yu, et al.. (2005). siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication. Gene Therapy. 12(9). 751–761. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact